Clinical Overview of AQ Advanced Hair Complex+: A Growth Factor–Based Mesotherapy Approach to Androgenetic Alopecia & Non-Scarring Hair Loss
- NW Aesthetics
- Dec 16, 2025
- 3 min read

AQ Advanced Hair Complex+ (AQ Skin Solutions, USA) is a growth factor–rich, non-hormonal injectable/mesotherapy serum designed to support follicular regeneration, restore hair cycling, and improve hair density in patients with androgenetic alopecia, telogen effluvium, and non-scarring alopecia.
This technical review provides clinicians with a detailed understanding of its composition, biological mechanism, clinical applications, and treatment protocols.
1. Composition & Active Biomolecules
AQ Advanced Hair Complex+ contains Human Fibroblast Conditioned Media (HFCM), which is a controlled blend of recombinant growth factors secreted by cultured human fibroblasts under GMP conditions.
Key Growth Factors & Their Roles
Growth Factor | Mechanism of Action | Clinical Benefit |
VEGF (Vascular Endothelial Growth Factor) | Angiogenesis, increased perifollicular circulation | Enhances follicular nutrition & oxygenation |
IGF-1 (Insulin-like Growth Factor-1) | Promotes follicular proliferation, prolongs anagen phase | Increases hair shaft diameter & density |
KGF (Keratinocyte Growth Factor) | Keratinocyte stimulation | Strengthens shaft structure & improves quality |
bFGF (Basic Fibroblast Growth Factor) | Stem cell activation; dermal papilla stimulation | Supports growth of miniaturised follicles |
Additionally, the formula contains proprietary peptides, cytokines, and bioactive proteins that support:
Anti-inflammatory activity
Improved ECM (extracellular matrix) turnover
Follicular stem cell microenvironment repair
2. Scientific Rationale: Why Growth Factors?
Androgenetic alopecia involves:
Follicular miniaturisation
Reduced anagen phase
Microinflammation
Decreased perifollicular vascularity
Stem cell niche impairment
Growth factors address these pathological changes at the cellular level.
AQ Mechanism of Action Summary in Hair Mesotherapy
Upregulation of anagen-related signalling pathways (Wnt/β-catenin).
Activation of dermal papilla cells, reversing miniaturisation.
Increased perifollicular angiogenesis via VEGF.
Reduction of inflammatory mediators around follicles.
Enhanced keratinocyte activity, improving hair thickness.
Acceleration of cell turnover and ECM repair in the scalp.
This positions AQ Hair Complex+ as a regenerative therapy rather than a cosmetic solution.
3. Indications for Use
Primary Indications
Androgenetic alopecia (male & female pattern) — Grade I–IV
Telogen effluvium (subacute & chronic)
Age-related hair thinning
Diffuse hair loss due to stress, illness, or nutritional causes
Adjunctive Indications
Post-hair transplant for graft survival & density enhancement
Post-laser or microneedling scalp rejuvenation
PRP-resistant cases
Patients intolerant to minoxidil or finasteride
Patient Selection
Best suited for:
Early–moderate alopecia
Non-cicatricial hair loss
Patients seeking non-hormonal solutions
Patients preferring predictable, standardised biologics over autologous PRP
Individuals unwilling/unfit for pharmacological therapies
4. Clinical Protocol
In-Clinic Treatment Protocol
Total sessions: 5
Interval: Every 14 days
Dose: 1 vial (6 ml) per session
Administration:
Microneedling (0.5–1.0 mm scalp depth) OR
Nappage mesotherapy technique
Adjunctive Therapies
Low-level laser therapy (LLLT)
Oral nutraceuticals (biotin, antioxidants, amino acids)
Minoxidil (optional depending on patient compliance)
PRP (alternate sessions in resistant cases)
Maintenance
1 session every 3–4 months, depending on severity
5. Expected Clinical Outcomes
Timeline of Response
Timeframe | Clinical Observation |
2–3 weeks | Reduced shedding, improved scalp quality |
4–6 weeks | Increased hair anchoring, early anagen conversion |
8–12 weeks | Visible baby hair growth, improved density |
12–16 weeks | Increased volume, improved shaft thickness & coverage |
Quantitative Improvements (based on available literature & real-world users)
20–40% reduction in shedding by week 4
15–30% increase in density by week 12
Improved hair calibre and tensile strength
6. Advantages Over PRP & Conventional Mesotherapy
PRP Limitations
Variability in platelet concentration
Dependent on patient health
Pain & downtime
Not suitable for all patients (anemia, low platelet count)
AQ Advantages
Standardised concentration of growth factors
Predictable, reproducible outcomes
Higher purity and no inflammatory proteins
Minimal discomfort
No dependence on patient physiology
Compared to mesotherapy cocktails (vitamins/peptides), AQ offers bio-identical signalling molecules that act directly on the follicular microenvironment.
7. Safety Profile
AQ Hair Complex+ demonstrates an excellent safety profile:
Non-hormonal
Non-cytotoxic
No systemic absorption
No risk of allergic reactions (biocompatible proteins)
Minimal erythema post-application
Common but minor and transient reactions:
Mild redness
Temporary scalp sensitivity
Microneedling-induced pinpoint bleeding
No long-term adverse effects have been reported in literature or real-world usage.
8. Combination Protocols of AQ Hair Mesotherapy for Enhanced Results
1. AQ + PRP (Sequential Therapy)
Ideal for resistant androgenetic alopecia.PRP stimulates platelets; AQ provides consistent regenerative signalling.
2. AQ + LLLT
Improves microcirculation and ATP production; enhances growth factor uptake.
3. AQ + Exosomes (High-end clinics)
Synergistic regenerative effect for advanced alopecia.
4. AQ Post-Transplant Protocol
Start at week 3–4 post-transplant
3 sessions recommended. Improves graft survival and vascularisation.
9. Contraindications
Active scalp infections
Active dermatitis/psoriasis flare
Pregnant or lactating patients (precautionary)
Recent use of isotretinoin (<6 months)
Known hypersensitivity to microneedling
The product itself has no known allergenic triggers.
10. Clinical Summary
AQ Advanced Hair Complex+ hair mesotherapy offers doctors a scientifically grounded, non-hormonal, reproducible, and patient-compliant solution for managing early-to-moderate hair loss.
It excels in:
Follicular regeneration
Density improvement
Reduction of hair shedding
Enhancing anagen phase duration
Improving hair shaft quality
Supporting post-transplant healing
Its growth factor technology fills a crucial gap between pharmaceutical treatments (minoxidil/finasteride) and autologous biologics (PRP) — providing a high-value, standardised, and safer alternative.







Comments